Dr. Kathryn L. Laurie
Claim this profileMorristown Medical Center
Expert in Brain Tumor
Expert in Lymphoma
47 reported clinical trials
98 drugs studied
About Kathryn L. Laurie
Education:
- Obtained MD from Rutgers Robert Wood Johnson Medical School in 2015.
- Completed Residency in Internal Medicine at Morristown Medical Center in 2018.
- Finished Fellowship in Hematology and Oncology at Morristown Medical Center in 2021.
Experience:
- Currently serves as a Hematology and Oncology specialist at Morristown Medical Center.
Area of expertise
1Brain Tumor
Global LeaderStage I
Stage II
Stage IV
2Lymphoma
Global LeaderPhiladelphia chromosome positive
BCR-ABL1 fusion positive
ABL-class fusion positive
Affiliated Hospitals
Clinical Trials Kathryn L. Laurie is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Kathryn L. Laurie
Clinical Trial Related7 years of experience running clinical trials · Led 47 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Kathryn L. Laurie has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Vincristine Sulfate
- Doxorubicin Hydrochloride
- Methotrexate
Breakdown of trials Kathryn L. Laurie has run
Brain Tumor
Lymphoma
Head and Neck Cancers
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathryn L. Laurie specialize in?
Kathryn L. Laurie focuses on Brain Tumor and Lymphoma. In particular, much of their work with Brain Tumor has involved Stage I patients, or patients who are Stage II.
Is Kathryn L. Laurie currently recruiting for clinical trials?
Yes, Kathryn L. Laurie is currently recruiting for 18 clinical trials in Morristown New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Kathryn L. Laurie has studied deeply?
Yes, Kathryn L. Laurie has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Kathryn L. Laurie?
Apply for one of the trials that Kathryn L. Laurie is conducting.
What is the office address of Kathryn L. Laurie?
The office of Kathryn L. Laurie is located at: Morristown Medical Center, Morristown, New Jersey 07960 United States. This is the address for their practice at the Morristown Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.